Foundations
Depressive Disorders
Michael Thase, MD
Professor of Psychiatry
Perelman School of Medicine at the University of Pennsylvania SOM
Perelman School of Medicine at the University of Pennsylvania SOM
A new feature at Psych Congress in 2023, each Foundations in Psychopharmacology session will dive deep into one specific therapeutic drug class, such as antidepressants or antipsychotics. These sessions are distinct in their foundational emphasis on both long-standing medications often appropriate as first-line therapies, as well as additional first-line options and adjunctive treatments. Foundations sessions may be particularly valuable for early-career psychopharmacologists and those looking for a detailed look at the when and the why of medication selection as well as access-related challenges and considerations that may affect treatment decisions.
This session will delve into the foundational approaches to antidepressant therapies, examining both traditional medicines and new treatments currently available on the market. Attendees will gain a comprehensive understanding of the mechanisms of action behind antidepressant medications and the ways in which they can be used to treat depression and related mood disorders.